Aemetis (NASDAQ:AMTX) Announces Earnings Results, Beats Estimates By $0.01 EPS

Aemetis (NASDAQ:AMTX) announced its quarterly earnings data on Thursday. The specialty chemicals company reported ($0.34) earnings per share for the quarter, beating the consensus estimate of ($0.35) by $0.01, Yahoo Finance reports. The firm had revenue of $70.76 million during the quarter, compared to the consensus estimate of $80.08 million. During the same period in the prior year, the firm earned ($0.63) earnings per share.

Aemetis Stock Up 3.1 %

AMTX stock opened at $3.36 on Friday. The company has a 50-day simple moving average of $3.69 and a 200 day simple moving average of $4.40. Aemetis has a fifty-two week low of $1.16 and a fifty-two week high of $8.99.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on AMTX shares. Truist Financial dropped their target price on shares of Aemetis from $5.00 to $3.50 and set a “hold” rating on the stock in a report on Tuesday, January 23rd. Stifel Nicolaus decreased their target price on shares of Aemetis from $8.00 to $6.50 and set a “buy” rating for the company in a research report on Wednesday, February 21st.

Hedge Funds Weigh In On Aemetis

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Charles Schwab Investment Management Inc. lifted its holdings in shares of Aemetis by 3.1% during the first quarter. Charles Schwab Investment Management Inc. now owns 75,306 shares of the specialty chemicals company’s stock valued at $955,000 after purchasing an additional 2,254 shares during the last quarter. JPMorgan Chase & Co. boosted its stake in Aemetis by 16.0% in the 1st quarter. JPMorgan Chase & Co. now owns 16,362 shares of the specialty chemicals company’s stock worth $208,000 after purchasing an additional 2,256 shares during the period. Guggenheim Capital LLC grew its stake in Aemetis by 18.7% during the 3rd quarter. Guggenheim Capital LLC now owns 17,879 shares of the specialty chemicals company’s stock valued at $110,000 after acquiring an additional 2,818 shares in the last quarter. Point72 Asset Management L.P. acquired a new position in Aemetis in the 2nd quarter valued at approximately $25,000. Finally, Tower Research Capital LLC TRC raised its holdings in shares of Aemetis by 173.7% during the third quarter. Tower Research Capital LLC TRC now owns 5,586 shares of the specialty chemicals company’s stock worth $34,000 after acquiring an additional 3,545 shares in the last quarter. 27.95% of the stock is owned by institutional investors.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the acquisition, development, and commercialization of negative carbon intensity products and technologies that replace traditional petroleum-based products.